[Form 4] Arteris, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Arteris, Inc. reporting person Janac K. Charles disclosed insider sales executed under a 10b5-1 trading plan adopted on 03/05/2025. The filing shows a weighted-average sale of $13.0742 for 50,000 shares sold on 10/08/2025. After the reported transactions, the reporting person is listed as having 9,689,071 shares beneficially owned indirectly through Bayview Legacy, LLC, and additional holdings are noted through the Charles and Lydia Janac Trust. The report was signed by an attorney-in-fact on 10/10/2025. The sale is identified as made pursuant to a pre-established trading plan and the filing discloses the range of execution prices between $13.00 and $13.20.

Positive

• Sale executed under a 10b5-1 plan, which provides an affirmative defense and pre-planned execution
• Large retained indirect ownership remains: 9,689,071 shares held via Bayview Legacy, LLC
• Weighted-average sale price disclosed ($13.0742) with execution price range provided

Negative

• Insider disposed of 50,000 shares on 10/08/2025, representing a liquidating transaction that may reduce insider holdings
• Additional disposals listed (e.g., 161,759 shares shown as disposed on the table) that merit clarification in future filings

Insights

Corporate Governance Analyst

TL;DR: A director/CEO sold a small percentage of holdings under a pre-set plan while retaining large indirect ownership.

The sale of 50,000 shares at a weighted-average price of $13.0742 was executed under a 10b5-1 plan adopted on 03/05/2025, which provides an affirmative defense to insider trading claims when properly documented. The filing also lists additional disposals and trust/LLC holdings, with 9,689,071 shares held indirectly via Bayview Legacy, LLC.

Reliance on a trading plan reduces regulatory uncertainty but does not address investor perception; monitor any future filings for changes in planned sales or material transfers within 30 days to assess trend. Track subsequent Form 4s for patterns in volume or timing relative to company disclosures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/08/2025		S(1)		50,000	D	$13.0742(2)	9,689,071	I	Bayview Legacy, LLC(3)
Common Stock								161,759	D
Common Stock								56,252	I	Charles and Lydia Janac Trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.20 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Janac K. Charles report on Form 4 for Arteris (AIP)?

Janac K. Charles reported sales of shares on 10/08/2025, including 50,000 shares sold at a weighted-average price of $13.0742, under a 10b5-1 plan.

Was the sale by the Arteris (AIP) insider part of a trading plan?

Yes. The sale was made pursuant to a 10b5-1 trading plan adopted on 03/05/2025, as disclosed in the filing.

How many Arteris (AIP) shares does the reporting person still beneficially own?

The filing shows 9,689,071 shares beneficially owned indirectly through Bayview Legacy, LLC, plus additional holdings via the Charles and Lydia Janac Trust.

What price range were the sold Arteris (AIP) shares executed at?

The filing states the shares were sold at prices ranging from $13.00 to $13.20, with a weighted-average of $13.0742.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney-in-fact on 10/10/2025.